- Direction
- Improving
- Own history
- —
- Peers
- 88th
- Persistence
- EMERGING
· Pharmaceutical Preparations
RESEARCH SNAPSHOTBICYCLE THERAPEUTICS PLC's latest supported as-filed period reports revenue of $34.1M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.90% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -118.34% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 190.24% · CORE
Level · gp.fundamentals.operating_margin
Raw value -39.57% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 98.14% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 15.91% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 190.2%; Operating margin moved 51907 bp higher; Operating income increased 79.4%.
3 evidence-backed componentsCurrent liabilities changed -38.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
BCYC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-119864SEC ↗8-KOct 29, 2026Period Oct 29, 20260001104659-26-119858SEC ↗4/AOct 7, 2026Period Oct 2, 20260002119908-26-000013SEC ↗4Oct 6, 2026Period Oct 2, 20260002079922-26-000006SEC ↗4Oct 6, 2026Period Oct 2, 20260001776582-26-000010SEC ↗4Oct 6, 2026Period Oct 2, 20260002015378-26-000010SEC ↗4Oct 6, 2026Period Oct 2, 20260002119908-26-000011SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 5, 2026Filed Oct 7, 2026 | Perry Jennifer ScottChief Operating Officer | Open Market SaleDirect · amended | 30 | $4 | $107 | Form 4 ↗ |
| Oct 5, 2026Filed Oct 7, 2026 | Perry Jennifer ScottChief Operating Officer | Open Market SaleDirect · amended | 326 | $4 | $1,232 | Form 4 ↗ |
| Oct 5, 2026Filed Oct 6, 2026 | Thompson Travis AlvinChief Financial Officer | Open Market SaleDirect | 79 | $4 | $282 | Form 4 ↗ |
| Oct 2, 2026Filed Oct 6, 2026 | Thompson Travis AlvinChief Financial Officer | Open Market SaleDirect | 893 | $3 | $3,099 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Free-cash-flow proxy changed +43.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +37.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +79.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +43.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -570810 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -35.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001776938-26-000008| Oct 2, 2026Filed Oct 6, 2026 |
| Swanton Robert CharlesDirector |
| Open Market SaleDirect |
| 3,431 |
| $3 |
| $11,906 |
| Form 4 ↗ |
| Jul 15, 2026Filed Jul 17, 2026 | Thompson Travis AlvinChief Financial Officer | Grant Or AwardDirect | 60,000 | $0 | $0 | Form 4 ↗ |